[{"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":74300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":74.6,"CommonStockSharesConverted_0_FY_shares":74700000.0,"Assets_0_FY_USD":1404600000.0,"RevenuesConverted_1_FY_USD":93200000.0,"RevenuesConverted_4_FY_USD":638600000.0,"NetIncomeLossConverted_4_FY_USD":-199600000.0,"StockholdersEquity_0_FY_USD":918200000.0,"CommonStockSharesOutstanding_0_FY_shares":74700000.0,"EarningsPerShareDiluted_1_FY_USD":-0.74,"EarningsPerShareDiluted_4_FY_USD":-2.69,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":60700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":74300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":74.6,"StockholdersEquityConverted_0_FY_USD":918200000.0,"NetIncomeLossConverted_1_FY_USD":-55400000.0,"EarningsPerShareBasic_1_FY_USD":-0.74,"EarningsPerShareBasic_4_FY_USD":-2.69,"Ticker":"MYGN","CIK":"899923","name":"MYRIAD GENETICS INC","OfficialName":"Myriad Genetics Inc. Common Stock","form":"10-K","period":"20200630","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"1850258412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200813"}]